Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer
Completed · Phase 1 · Has a placebo group
Conditions studied: Breast Cancer
In brief
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. Indole-3-carbinol may be effective in preventing breast cancer. PURPOSE: Phase I trial to study the effectiveness of indole-3-carbinol in preventing breast cancer in nonsmoking women who are at high risk for breast cancer.
Key facts
- Study ID
- NCT00033345
- Run by
- University of Kansas Medical Center
- People needed
- 17
- Starts
- 2002-01-01
- Last updated by the study team
- 2016-08-18
Who can join
Age: 18 and older, up to 70. Sex: female. Healthy volunteers: not accepted.
Where it is running
- University of Kansas Medical Center — Kansas City, Kansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.